Follow Us
https://www.thebody.com/author/avac-global-advocacy-for-hiv-prevention

AVAC: Global Advocacy for HIV Prevention

AVAC: Global Advocacy for HIV Prevention was founded in December 1995 to advocate for the development of a safe, effective, and accessible HIV vaccine. It seeks to promote increased funding and investment in HIV vaccine research by government agencies, private industry and non-governmental organizations; to identify barriers to the development of a vaccine; and to increase public awareness about the need for a well funded, coordinated HIV vaccine research program. It seeks to promote increased HIV vaccine advocacy efforts by community-based organizations and increased awareness about HIV vaccine development among AIDS-affected communities. It is committed to the principle that funds for HIV vaccine research are not to be taken from basic HIV research, drug development or prevention efforts.

Latest by AVAC: Global Advocacy for HIV Prevention

AVAC at HIVR4P: How We Carry On Img
News

AVAC at HIVR4P: How We Carry On

"Every member of the AVAC team in Madrid was moved and motivated by the Madrid conference," AVAC writes. "We know the work is not easy, nor is the world."

Real Women Don't Look Like Models: What the Latest Paper on Hormonal Contraception and HIV Risk Leaves Out Img
News

Real Women Don't Look Like Models: What the Latest Paper on Hormonal Contraception and HIV Risk Leaves Out

While there are modeling studies that look at lives saved versus lost because of these contraception methods, advocates are calling far and wide for better choices.

Voluntary Medical Male Circumcision: The Basics Img

Voluntary Medical Male Circumcision: The Basics

What is medical male circumcision and why is it a key part of combination HIV prevention? This fact sheet answers these questions and more.

Microbicides: The Basics Img
Viewpoints

Microbicides: The Basics

What are microbicides, why do we need them, and what is the status of current microbicide research? This fact sheet answers those questions and more.

DAIDS Boss Muses on the Future of HIV Prevention Research Img
Viewpoints

DAIDS Boss Muses on the Future of HIV Prevention Research

Carl Dieffenbach, Ph.D., director of NIH's Division of AIDS, recently met with advocates to provide them with his "rather intentionally provocative ideas, which will for sure get varying degrees of attention, praise and criticism."

PrEP Stymied in Europe: What's the Hold Up? Img
News

PrEP Stymied in Europe: What's the Hold Up?

Europe is the birthplace of the smallpox vaccine and the Renaissance, among other treasures. So why can't this continent that has brought forth such cornerstones of public health and flourishing civilization deliver oral PrEP?

Webinar With WHO on Hormonal Contraception and HIV Img

Webinar With WHO on Hormonal Contraception and HIV

You're invited to join a webinar with the World Health Organization on the newly released guidance on hormonal contraceptive eligibility for women at high risk of HIV.

Webinar, Feb. 9: 'Time to Protection' on PrEP Img

Webinar, Feb. 9: 'Time to Protection' on PrEP

Protection from pre-exposure prophylaxis doesn't happen overnight. How many doses does it take? Join AVAC for a webinar on the data behind "time to protection for PrEP."

Money, Drugs and Labor: Economist Jeffrey Sachs' Solution to Ending the HIV/AIDS Crisis Img
News

Money, Drugs and Labor: Economist Jeffrey Sachs' Solution to Ending the HIV/AIDS Crisis

"President Clinton should lay the foundation for ending the HIV/AIDS crisis by 2030," says Jeffrey Sachs, expert on global economic development and provocateur. "Tell her to knock down drug prices in the U.S. ... raise a miniscule US$10 billion a yea...

Debate This: What Do HIV Prevention and Elections Have in Common? Img
Viewpoints

Debate This: What Do HIV Prevention and Elections Have in Common?

"When scientists work with (or as) advocates, or when politicians serve as (or team up with) activists, great things can happen," AVAC writes from the HIV Research for Prevention conference in Chicago.